Anixa Biosciences, Inc.
ANIX
$3.30
-$0.11-3.23%
NASDAQ
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -17.85% | -8.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.88% | -11.31% | |||
| Operating Income | 18.88% | 11.31% | |||
| Income Before Tax | 18.95% | 12.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.95% | 12.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -4.35% | -20.69% | |||
| Net Income | 19.07% | 12.37% | |||
| EBIT | 18.88% | 11.31% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 19.75% | 12.44% | |||
| Normalized Basic EPS | 19.85% | 12.36% | |||
| EPS Diluted | 19.75% | 12.44% | |||
| Normalized Diluted EPS | 19.85% | 12.36% | |||
| Average Basic Shares Outstanding | 0.85% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.85% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||